Virtu KCG Holdings’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Virtu KCG Holdings’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-32,783	Closed	-$43K	–	3805
2016 Q2	$43K	Buy	+32,783	New	+$52.5K	﹤0.01%	2708
2015 Q2	–	Sell	-12,695	Closed	-$27K	–	4043
2015 Q1	$27K	Sell	12,695 -4,115	-24%	-$9.64K	﹤0.01%	2918
2014 Q4	$23K	Sell	16,810 -11,472	-41%	-$9.99K	﹤0.01%	3585
2014 Q3	$23K	Buy	+28,282	New	+$50.9K	﹤0.01%	3458
2014 Q2	–	Sell	-11,859	Closed	-$36K	–	4316
2014 Q1	$36K	Sell	11,859 -435	-4%	-$1.43K	﹤0.01%	3381
2013 Q4	$38K	Buy	+12,294	New	+$34.3K	﹤0.01%	3648

Other funds holding ECTE

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Virtu KCG Holdings's ECTE Position: Q3 2016 in Review

Virtu KCG Holdings sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 32,783 shares — an estimated $43K sold.

Virtu KCG Holdings first reported a position in ECTE in Q4 2013 and held it in 6 quarters. The position peaked at $43K in Q2 2016. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

Virtu KCG Holdings reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
Virtu KCG Holdings sold 32,783 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016, an estimated $43K.
Virtu KCG Holdings first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q4 2013 and held it in 6 quarters.
Virtu KCG Holdings's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $43K in Q2 2016.
2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on Virtu KCG Holdings's 13F filing for Q3 2016, filed 10 Nov 2016.